Michinori Ogura

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

Takashi Ishida, Tatsuro Joh, Naokuni Uike et al. · Journal of Clinical Oncology · 2012 · 639 citations · Full text

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

Hagop M. Kantarjian, Neil P. Shah, Jörge E. Cortes et al. · Blood · 2011 · 601 citations · Full text

Senile EBV+ B-Cell Lymphoproliferative Disorders

Takashi Oyama, Koichi Ichimura, Ritsuro Suzuki et al. · The American Journal of Surgical Pathology · 2003 · 395 citations

Lymphoid Neoplasia, Autoimmune Disease, Elderly Patients +14

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Michinori Ogura, Takashi Ishida, Kiyohiko Hatake et al. · Journal of Clinical Oncology · 2014 · 357 citations · Full text

Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma

Kazuhito Yamamoto, Atae Utsunomiya, Kensei Tobinai et al. · Journal of Clinical Oncology · 2010 · 350 citations · Full text